New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis

Ana F. Castillo(Consejo Nacional de Investigaciones Científicas y Técnicas), Ernesto J. Podestá(Consejo Nacional de Investigaciones Científicas y Técnicas)
Cellular and Molecular Life Sciences
October 17, 2020
10.1007/s00018-020-03679-5
Cited by 75

Related Papers

Intermediate role of adenosine 3′:5′-cyclic monophosphate and protein kinase during gonadotropin-induced steroidogenesis in testicular interstitial cells
|Proceedings of the National Academy of Sciences|1977|213
Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer
|Oncotarget|2015|51